AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services. With nearly 800 employees operating out of seven sites in the US and Europe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability services.
Our capabilities include preformulation services, formulation development, scale-up, manufacturing, analytical development and stability to support oral solid dose and parenteral formulations.
Our network of testing laboratories offers fast turnaround for microbiology, compendial testing, release and stability testing on active pharmaceutical ingredients, drug products and packaging components.
We offer cGMP solid oral dose and parenteral dose manufacturing capabilities, including small and large molecules with the flexibility to support early product development through commercial supply.